Navigation Links
Cepheid Reports Fourth Quarter And Full Year 2012 Results
Date:1/24/2013

HBDC program," said John Bishop, Cepheid's Chief Executive Officer.  "Despite these distractions, we were able to grow our clinical test revenue by 32%, including 25% growth in our commercial business."

Continued Bishop, "We are proud of our commitment to innovation, and our investment in R&D continues to be among the most aggressive in the industry.  As we move into 2013 and beyond, Cepheid is entering a pivotal period of Xpert test menu expansion with a number of high volume, high value tests that substantially extend our opportunities in new and existing markets.  We fully expect this product cycle to drive both market expansion and menu consolidation within accounts thereby benefiting continued, industry-leading revenue growth and improving profitability."

Operational Overview

  • Fourth quarter of 2012 Clinical sales of $82.2 million grew 19% from $68.9 million in the fourth quarter of 2011, and total fourth quarter of 2012 product sales of $89.7 million grew 17% from the same quarter a year ago.  For the year ended December 31, 2012, total Clinical sales of $286.3 million grew 21% from $236.0 million reported for 2011. 
  • By industry, product sales were, in millions:
    • Three Months Ended December 31,Full Year Ended December 31,20122011Change20122011ChangeClinical Systems

    $  13.4$  19.9-33%$
    52.8$
    58.6-10%Clinical Reagents

    68.849.040%233.5177.432%Total Clinical 82.268.919%286.3236.021%Non-Clinical

    7.58.0-6%35.229.519%Total Product Sales$  89.7$  76.917%$  321.5$  265.521%


  • By geography, product sales were, in millions:
    • Three Months Ended December 31,Full Year Ended December 31,20122011Change20122011ChangeNorth AmericaClinical

    $  54.4$  46.417%$  190.0$  167.913%Other

    6.07.2-17%29.025.016%Total North America60.453.613%219.0192.914%InternationalClinical

    27.822.524%96.368.
    '/>"/>

    SOURCE Cepheid
    Copyright©2012 PR Newswire.
    All rights reserved

    0

    GOOD

    Page: 1 2 3 4 5 6 7 8 9 10 11 12

    Related medicine technology :

    1. Cepheid to Webcast Upcoming Financial Presentations
    2. Cepheid Announces Executive Vice President Emerging Markets
    3. Qmed, the Leading Global MedTech Industry Resource, Partners with Clarimed, to Provide the Medical Manufacturing and Healthcare Industry with FDA Reports on Adverse Events
    4. Sigma-Aldrich (NASDAQ: SIAL) Reports Q1 2012 Diluted EPS of $0.96, With Diluted Adjusted EPS of $0.99. Sales Increase 5% for Q1 2012. Full Year 2012 Diluted Adjusted EPS Outlook of $3.90 to $4.05 Reaffirmed.
    5. Kelyniam Global Inc. Reports Record Cranial Implant Revenues in the 1st Quarter of 2012
    6. Varian Medical Systems Reports Results for Second Quarter of Fiscal Year 2012
    7. Mylan Reports Q1 2012 Adjusted Diluted EPS of $0.52, an 18% Increase Over Prior Year Quarter
    8. CryoLife Reports Record Quarterly Revenues in First Quarter of 2012
    9. PAREXEL Reports Third Quarter Fiscal Year 2012 Financial Results
    10. Luminex Corporation Reports First Quarter 2012 Results
    11. Hospira Reports First-Quarter 2012 Results
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:5/23/2013)... 23, 2013  Omeros Corporation (NASDAQ: ... Drug Application (IND) to evaluate OMS824 in Huntington,s ... and Drug Administration (FDA). OMS824 selectively inhibits phosphodiesterase ... the brain linked to a wide range of ... schizophrenia. OMS824 has shown promising results in animal ...
    (Date:5/23/2013)... 2013 SynCardia Systems, Inc. ( www.syncardia.com ), ... Canada and CE ( Europe ) approved ... Centre in Scotland , which boasts ... SynCardia temporary Total Artificial Heart powered by the ... Bodyworks Exhibition, one of the most advanced exhibitions of ...
    (Date:5/23/2013)... International Corporation (NASDAQ: PRXL ) announced today ... Conference in New York.  James Winschel, Sr. ... be making a presentation on PAREXEL and discussing business ... A live webcast of the presentation will ... at www.PAREXEL.com in the Upcoming Events portion ...
    Breaking Medicine Technology:Investigational New Drug Application Cleared by FDA for OMS824 in Huntington's Disease 2Investigational New Drug Application Cleared by FDA for OMS824 in Huntington's Disease 3Investigational New Drug Application Cleared by FDA for OMS824 in Huntington's Disease 4Glasgow Science Centre Features SynCardia Total Artificial Heart in $3 Million Exhibition 2Glasgow Science Centre Features SynCardia Total Artificial Heart in $3 Million Exhibition 3PAREXEL International To Present At Jefferies Healthcare Conference 2
    ... Surgery Foundation Announces Speakers, Moderators and Panelists for 2nd International Symposium on MR-Guided Focused ... CHARLOTTESVILLE, Va. , June ... to speak at the 2nd International Symposium for MR-guided Focused Ultrasound, which will be ... , , , ...
    ... , SANTA BARBARA, Calif. , June 25 ... Diabetes Research Institute (Sansum) announced today the achievement of a milestone ... Foundation (JDRF). , , ... The world,s most flexible artificial pancreas system platform, currently being used ...
    Cached Medicine Technology:Leading Experts to Speak at Focused Ultrasound Symposium 2Leading Experts to Speak at Focused Ultrasound Symposium 3Leading Experts to Speak at Focused Ultrasound Symposium 4Leading Experts to Speak at Focused Ultrasound Symposium 5Leading Experts to Speak at Focused Ultrasound Symposium 6JDRF Reaches Milestone in Artificial Pancreas Project in Partnership with UC Santa Barbara and Sansum Diabetes Research Institute 2JDRF Reaches Milestone in Artificial Pancreas Project in Partnership with UC Santa Barbara and Sansum Diabetes Research Institute 3JDRF Reaches Milestone in Artificial Pancreas Project in Partnership with UC Santa Barbara and Sansum Diabetes Research Institute 4JDRF Reaches Milestone in Artificial Pancreas Project in Partnership with UC Santa Barbara and Sansum Diabetes Research Institute 5JDRF Reaches Milestone in Artificial Pancreas Project in Partnership with UC Santa Barbara and Sansum Diabetes Research Institute 6
    (Date:5/23/2013)... Symptoms of borderline personality disorder often mimic traits ... But researchers in Canada say they have identified ... personality disorder: a tendency to misinterpret emotions expressed ... processing facial emotions and will see a negative ... a clinical neuropsychologist and assistant professor at the ...
    (Date:5/23/2013)... HealthDay Reporter , , THURSDAY, May 23 (HealthDay ... teeth as badly as methamphetamine or crack cocaine, a ... with ,meth mouth, or ,coke mouth, it is startling ... or less the same," said Dr. Mohamed Bassiouny, a ... of Dentistry in Philadelphia. Methamphetamine, crack cocaine and ...
    (Date:5/23/2013)... -- Although a study in 2012 suggested a ... problems associated with Alzheimer,s disease, three groups of ... duplicate those findings. The teams said their ... since the drug involved in the study, bexarotene ... blood-lipid abnormalities, pancreatitis, headaches, fatigue, weight gain, depression, ...
    (Date:5/23/2013)... shown that an immune regulatory molecule called IL-21 is ... infections. , The results are published in the ... IL-21 could be important in the development of antiviral ... the first author of the paper. The senior author ... Center and a Georgia Research Alliance Eminent Scholar. , ...
    (Date:5/23/2013)... IL (PRWEB) May 23, 2013 ... comprehensive solutions and educational resources for the autism, ... that it is opening its first global autism ... the Philippines in August. This new world-class program ... best of Western evidence-based practices to treat and ...
    Breaking Medicine News(10 mins):Health News:People With Borderline Personality Disorder May Misinterpret Facial Emotions 2Health News:People With Borderline Personality Disorder May Misinterpret Facial Emotions 3Health News:Diet Soda Habit as Bad for Teeth as Meth Addiction, Study Claims 2Health News:Diet Soda Habit as Bad for Teeth as Meth Addiction, Study Claims 3Health News:Scientists Can't Replicate Surprising Finding on Alzheimer's Treatment 2Health News:Vaccine blackjack: IL-21 critical to fight against viral infections 2Health News:Special Learning, Inc. to Expand its Services for Individuals with Special Needs with Opening of New Special Education School in the Philippines 2Health News:Special Learning, Inc. to Expand its Services for Individuals with Special Needs with Opening of New Special Education School in the Philippines 3
    ... research from LifeMasters Supported SelfCare, Inc. shows that physicians who receive ... clinical status of their patients, responded quickly to the results with ... , ... Irvine, Calif. (Vocus) December 9, 2009-- New ...
    ... The United Spinal Association ( www.UnitedSpinal.org ) encourages wheelchair and ... call 311 to request a wheelchair-accessible taxi via ... This system links passengers who use wheelchairs with ... NYC can call 311 for a pre-arranged service. 311 connects ...
    ... leading provider of,safety, quality, and compliance solutions for ... Practices (ISMP), today announced a joint,collaboration to advance ... will,work with Quantros to provide ongoing MEDMARX analysis ... practices. Under this,agreement, Quantros and ISMP will ...
    ... Mayo Clinic researchers have found that a new ... improved or stabilized multiple myeloma for 76 percent ... , Interim results of an ongoing clinical ... with dexamethasone (pom/dex), were presented today at the ...
    ... international coalition of pediatric cancer physicians and researchers has ... the world. In the December issue of the ... Group (INRG) presents three sets of papers outlining a: ... of a rare group of patients., The INRG studies ...
    ... Wyeth (NYSE: WYE ) will announce financial results for ... hold a one-hour conference call with research analysts at 8:00 a.m. ... to discuss financial guidance for 2009 on this conference call. , ... listen to the call live or on a delayed basis through ...
    Cached Medicine News:Health News:Research Shows Successful Physician Engagement in LifeMasters Disease Management Programs 2Health News:Research Shows Successful Physician Engagement in LifeMasters Disease Management Programs 3Health News:Accessible Dispatch Program: Accessible Taxi Service for Wheelchair Users in New York City 2Health News:Quantros and ISMP Announce Collaboration Agreement to Further Medication Safety 2Health News:Quantros and ISMP Announce Collaboration Agreement to Further Medication Safety 3Health News:Drug combination improves or stabilizes disease for relapsed multiple myeloma patients 2Health News:Children's cancer group recommends global evaluation system for neuroblastoma to improve treatment 2
    ... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
    ... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
    ... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
    ... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
    Medicine Products: